These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 2562436

  • 1. PAF receptor. 2. Quantitative hydrophobic contribution of the agonist's etheroxid chain.
    Heymans F, Steiner E, Jouquey S, Godfroid JJ.
    J Lipid Mediat; 1989; 1(5):303-12. PubMed ID: 2562436
    [Abstract] [Full Text] [Related]

  • 2. Structure-activity relationships for platelet-activating factor (PAF) and analogues reveal differences between PAF receptors on platelets and macrophages.
    Stewart AG, Grigoriadis G.
    J Lipid Mediat; 1991 Nov; 4(3):299-308. PubMed ID: 1662547
    [Abstract] [Full Text] [Related]

  • 3. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
    Ostermann G, Hofmann B, Kertscher HP, Till U.
    J Lipid Mediat; 1990 Nov; 2(1):21-31. PubMed ID: 1966804
    [Abstract] [Full Text] [Related]

  • 4. Agonistic activity and charge driven interaction potentiality of PAF derivatives.
    Villa L, Pallavicini M, Villa AM, Valoti E, Ferri V, Berti F.
    Farmaco; 1993 Oct; 48(10):1379-99. PubMed ID: 8117380
    [Abstract] [Full Text] [Related]

  • 5. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
    Lakin KM, Kulikov VI, Manevich EM, Muliar AG, Shvets VI.
    Farmakol Toksikol; 1988 Oct; 51(4):113-23. PubMed ID: 2847936
    [No Abstract] [Full Text] [Related]

  • 6. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
    Imanishi N, Murakami-Uchida M, Koike H, Natsume Y, Morooka S.
    Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
    [Abstract] [Full Text] [Related]

  • 7. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
    Hwang SB, Lam MH, Alberts AW, Bugianesi RL, Chabala JC, Ponpipom MM.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):534-41. PubMed ID: 2841449
    [Abstract] [Full Text] [Related]

  • 8. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
    Doebber TW, Wu MS, Biftu T.
    J Immunol; 1986 Jun 15; 136(12):4659-68. PubMed ID: 3011900
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC, Seldon PM, Barnes PJ, Giembycz MA.
    Mol Pharmacol; 1993 Feb 15; 43(2):302-12. PubMed ID: 8381515
    [Abstract] [Full Text] [Related]

  • 10. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L, Floch A, Mondot S, Cavero I.
    Mol Pharmacol; 1988 Aug 15; 34(2):145-51. PubMed ID: 2842653
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
    Bastos da Silva M, Delaunois A, Gustin P, Godeau JM, Lekeux P.
    Vet Res; 2000 Aug 15; 31(2):267-72. PubMed ID: 10779205
    [Abstract] [Full Text] [Related]

  • 13. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor.
    Bennett SA, Birnboim HC.
    Mol Carcinog; 1997 Dec 15; 20(4):366-75. PubMed ID: 9433481
    [Abstract] [Full Text] [Related]

  • 14. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
    Chen J, Giri SN.
    J Pharmacol Exp Ther; 1997 Jun 15; 281(3):1047-58. PubMed ID: 9190835
    [Abstract] [Full Text] [Related]

  • 15. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro.
    Cardile V, Mascarucci P, De Simoni MG, Jiang X, Bindoni M.
    Cytokine; 1996 Sep 15; 8(9):698-701. PubMed ID: 8932980
    [Abstract] [Full Text] [Related]

  • 16. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB, Li CL, Lam MH, Shen TY.
    Lab Invest; 1985 Jun 15; 52(6):617-30. PubMed ID: 3925239
    [Abstract] [Full Text] [Related]

  • 17. [Platelet-activating factor-from molecular biology to clinic].
    Shimizu T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Dec 15; 32 Suppl():8-15. PubMed ID: 7602849
    [Abstract] [Full Text] [Related]

  • 18. Autocrine stimulation of B lymphocytes by a platelet-activating factor receptor agonist, 1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine.
    Tordai A, Franklin RA, Johnson C, Mazer BD, Clay KL, Gelfand EW.
    J Immunol; 1994 Jan 15; 152(2):566-73. PubMed ID: 8283038
    [Abstract] [Full Text] [Related]

  • 19. Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing.
    Ma X, Bazan HE.
    Invest Ophthalmol Vis Sci; 2000 Jun 15; 41(7):1696-702. PubMed ID: 10845588
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.